Advanced search
Publication Cover
Leukemia & Lymphoma Volume 7, 1992 - Issue 1-2
Submit an article Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Attempted Prevention of Blast Crisis in Chronic Myeloid Leukemia by the use of Pulsed Doses of Cytarabine and Lomustine A Cancer and Leukemia Group B Study

Richard T. Silver New York Hospital-Cornell Medical Center, Section of Clinical Oncology (CA-07968), New York
,
Arthur Karanas St. Lukes/Roosevelt Hospital Center, Division of Hematology/Oncology, New York
,
Keith B. Dear Harvard School of Public Health, Department of Bio statistics, Boston, Mass. (CA-33601), Paris, France
,
Marise Weil Service d'Oncologie Medicale Hopital Pitie-Salpetriere, Paris, France
,
Kurt Brunner Swiss Group Against Cancer, Berne, Switzerland
,
Farid Haurani Thomas Jefferson University Hospital, Philadelphia, PA, (CA-05462)
&
James F. Holland Mount Sinai Medical Center, Department of Neoplastic Diseases, New York, (CA-04457)
 show all
Pages 63-68 | Received 11 Oct 1991, Published online: 01 Jul 2009

References

  • Silver R. T. Chronic myeloid leukemia: A prospective of the clinical and biologic issues of the chronic phase. Hematology/Oncology Clinics North America April, 1990; Vol 2
  • Silver R. T. The chronic leukemias. Conn Current Therapy, R. E. Rakel. W. B. Saunders & Co. 1987; 330–336
  • Spiers A. S. D., Baikie A. G. Evolution and clonal proliferation and acute transformation of chronic granulocytic leukemia. Brit. J. Cancer 1968; 22: 192
  • Pederson B., Killman S. Leukaemic subclones in chronic myelogenous leukemia. Acta Med. Scandia 1971; 190: 61–69
  • Cunningham M. I., Gee T., Dowling N. D., et al. Results of treatment of Ph (positive) chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol). Blood 1979; 53: 375
  • Silver R. T., Mick R., Degan T. J., Holland J. F., Cavelli F. Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytosine arabinoside and cis-chloronitrosurea during the course of busulfan maintained remission. A study of Cancer and Leukemia Group B. Cancer Investigation 1988; 6: 253–260
  • Silver R. T., Mick R., Cooper R., et al. A comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukemia. A study of Cancer and Leukemia Group B. Cancer 1987; 60: 1442–1448
  • Huguley Grizzle C. M., Rundles R. W. Comparison of 6-mercaptopurine and busulfan in chronic granulocytic leukemia. Blood 1963; 21: 89–101

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.